uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Tailored fluorouracil, epirubicin, and cyclophosphamide compared withmarrow-supported high-dose chemotherapy as adjuvant treatment forhigh-risk breast cancer: a randomised trial. Scandinavian Breast G
(CCK, KI, Stockholm)
Show others and affiliations
2000 (English)In: Lancet, Vol. 356, 1384- p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2000. Vol. 356, 1384- p.
Identifiers
URN: urn:nbn:se:uu:diva-57266OAI: oai:DiVA.org:uu-57266DiVA: diva2:85175
Available from: 2008-10-17 Created: 2008-10-17 Last updated: 2011-01-14

Open Access in DiVA

No full text

By organisation
Department of Oncology, Radiology and Clinical ImmunologyDepartment of Surgical Sciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 331 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf